ADAKVEO

NDC 0078-0883 · Novartis Pharmaceuticals Corporation

Generic namecrizanlizumab

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)CRIZANLIZUMAB

Strength10 mg/mL

Pharmacologic classP-Selectin Blockers [MoA], Selectin Blocker [EPC]

Marketing categoryBLA

Packages

0078-0883-61 — 10 mL in 1 VIAL, GLASS (0078-0883-61)

J0791 — Injection, crizanlizumab-tmca, 5 mg Medicare Part B payment limit (ASP + 6%): $129.94

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.